714-X

714-X or 714X, also called "trimethylbicyclonitramineoheptane chloride", is a drug manufactured by CERBE Distribution Inc. that is alleged to cure cancer, multiple sclerosis, fibromyalgia, and other "degenerative diseases". It was developed by Gaston Naessens, a native of France who has lived and worked in Quebec since the early 1970s. The efficacy of the drug is disputed, and the American Cancer Society has stated that "[t]here is no scientific evidence that 714-X is effective in treating any type of cancer or any other illness." No studies of its safety or efficacy in animals or humans have been published in any peer-reviewed, scientific journal. The marketers claim it works by counteracting the harm done by "somatids", a conjectured form of life which is alleged not to be bacterial, viral or fungal, but which instead form a distinct category, the existence of which is rejected by main-stream science and medicine.

While it is not known to be harmful no studies have been done to test its safety. FDA tests showed different batches contained a variety of different impurities, indicating a lack of quality control appropriate to the manufacture of medication. The Food and Drug Administration (FDA) has banned both importation and sale of 714-X, and at least one prison sentence has been handed down for importing it into America.

714-X is manufactured in Canada, where it is legal to purchase for personal use through a physician under the Emergency Drug Release Program of Health Canada, a "compassionate use" law which provides access to unproven treatments for terminal illnesses when no recognized alternative exists. However, Health Canada told the manufacturer to remove all references to the compound from its website.